1.New Development of Anti-HIV Drugs.
Journal of the Korean Medical Association 2001;44(1):86-94
No abstract available.
Anti-HIV Agents*
2.Treatment of AIDS.
Journal of the Korean Medical Association 1997;40(12):1567-1579
No abstract available.
3.No title in English
Journal of the Korean Medical Association 1997;40(6):678-689
No abstract available.
4.Atrial fibrillation in patient with Wolff-Parkinson-White syndrome mimicking ventricular tachycardia.
Korean Journal of Medicine 2002;62(3):320-321
No abstract available.
Atrial Fibrillation*
;
Humans
;
Tachycardia, Ventricular*
;
Wolff-Parkinson-White Syndrome*
5.A Case of Pigmented Malignant Hidroacanthoma Simplex.
Korean Journal of Dermatology 2016;54(10):830-831
No abstract available.
6.Therapeutic potential of resveratrol for the treatment of type III Gaucher disease
Neurology Asia 2015;20(1):43-48
Gaucher disease is the most common lysosomal storage disorder. Resveratrol is a natural polyphenol
that possesses a wide range of beneficial effects, including anti-inflammatory, anti-oxidant, and
neuroprotective activities. The aim of this study was to determine if resveratrol has a therapeutic
effect on primary fibroblast cells derived from a patient with type III Gaucher disease. 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays were performed to determine
the effect of resveratrol on cell survival. The expression levels of apoptosis-inducing factor (AIF),
Bcl-2-associated X protein (Bax), caspase-3, acetyl-coenzyme A acetyltransferase 1 (ACAT1), E3-
binding protein (E3BP), and citrate synthase (CS) were evaluated by western blotting to characterize
the effect of resveratrol treatment on Gaucher disease cells. Thin-layer chromatography (TLC) was
carried out to measure changes in glucosylceramide levels in resveratrol-treated patient cells. Resveratrol
increased the viability of patient cells compared to that of untreated control cells. Resveratrol treatment
dose-dependently decreased AIF, Bax, and cleaved caspase-3 levels, whereas ACAT1, E3BP, and CS
expression dose-dependently increased. TLC analysis showed reduced levels of glucosylceramides
in resveratrol-treated patient cells. These findings demonstrate that resveratrol can relieve cellular
stress due to glucosylceramide accumulation, and suggest that it should be studied further as a new
therapeutic approach for the treatment of Gaucher disease.
Gaucher Disease
7.Ventilator-Associated Peneumonia.
Korean Journal of Nosocomial Infection Control 2002;7(1):1-12
No abstract available.
8.Chronic gastric volvulus.
Journal of the Korean Surgical Society 1991;40(1):121-125
No abstract available.
Stomach Volvulus*
9.An Approach to Febrile Patients.
June Myung KIM ; Young Goo SONG
Journal of the Korean Medical Association 1998;41(1):49-55
No abstract available.
Humans
10.Solitary Pulmonary Nodule.
Journal of the Korean Medical Association 1999;42(3):292-297
No abstract available.
Solitary Pulmonary Nodule*